Geoff Macintyre
Geoff Macintyre
Computational Oncology Group Leader, CNIO, Madrid, Spain
Verified email at - Homepage
Cited by
Cited by
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
The evolutionary history of 2,658 cancers
M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ...
Nature 578 (7793), 122-128, 2020
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
MKH Hong*, G Macintyre*, DC Wedge*, P Van Loo, K Patel, S Lunke, ...
Nature Communications 6, 2015
Copy number signatures and mutational processes in ovarian carcinoma
G Macintyre, TE Goranova, D De Silva, D Ennis, AM Piskorz, M Eldridge, ...
Nature genetics 50 (9), 1262-1270, 2018
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ...
Cell 184 (8), 2239-2254. e39, 2021
Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells
L Pirola, A Balcerczyk, RW Tothill, I Haviv, A Kaspi, S Lunke, M Ziemann, ...
Genome research 21 (10), 1601-1615, 2011
Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array
H Naeem, NC Wong, Z Chatterton, MKH Hong, JS Pedersen, ...
BMC genomics 15, 1-15, 2014
Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
A Jiménez-Sánchez, P Cybulska, KLV Mager, S Koplev, O Cast, ...
Nature Genetics 52 (6), 582-593, 2020
is-rSNP: a novel technique for in silico regulatory SNP detection
G Macintyre, J Bailey, I Haviv, A Kowalczyk
Bioinformatics 26 (18), i524-i530, 2010
A pan-cancer compendium of chromosomal instability
RM Drews, B Hernando, M Tarabichi, K Haase, T Lesluyes, PS Smith, ...
Nature 606 (7916), 976-983, 2022
Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27+ Cell Population with Progenitor Characteristics
S Choudhury, V Almendro, VF Merino, Z Wu, R Maruyama, Y Su, ...
Cell stem cell, 2013
Prognostic gene expression signature for high-grade serous ovarian cancer
J Millstein, T Budden, EL Goode, MS Anglesio, A Talhouk, ...
Annals of Oncology 31 (9), 1240-1250, 2020
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads
J Schröder, A Hsu, SE Boyle, G Macintyre, M Cmero, RW Tothill, ...
Bioinformatics 30 (8), 1064-1072, 2014
Sequencing Structural Variants in Cancer for Precision Therapeutics
G Macintyre, B Ylstra, JD Brenton
Trends in Genetics 32 (9), 530-542, 2016
A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance
N Sapre, G Macintyre, M Clarkson, H Naeem, M Cmero, A Kowalczyk, ...
British journal of cancer 114 (4), 454-462, 2016
Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer
N Sapre, MKH Hong, G Macintyre, H Lewis, A Kowalczyk, AJ Costello, ...
PloS one 9 (4), e91729, 2014
Canonical androstenedione reduction is the predominant source of signaling androgens in hormone-refractory prostate cancer
M Fankhauser, Y Tan, G Macintyre, I Haviv, MKH Hong, A Nguyen, ...
Clinical Cancer Research 20 (21), 5547-5557, 2014
Development and validation of the gene expression predictor of high-grade serous ovarian carcinoma molecular SubTYPE (PrOTYPE)
A Talhouk, J George, C Wang, T Budden, TZ Tan, DS Chiu, S Kommoss, ...
Clinical Cancer Research 26 (20), 5411-5423, 2020
Genomic landscape of platinum resistant and sensitive testicular cancers
C Loveday, K Litchfield, PZ Proszek, AJ Cornish, F Santo, M Levy, ...
Nature Communications 11 (1), 2189, 2020
Inferring structural variant cancer cell fraction
M Cmero, K Yuan, CS Ong, J Schröder, NM Corcoran, T Papenfuss, ...
Nature communications 11 (1), 730, 2020
The system can't perform the operation now. Try again later.
Articles 1–20